CLINICAL_TRIALS
trial_result
· 2021-07-21
Clinical Trial Update: Phase III B in Acute Lymphoblastic Leukemia [Phase 3]
Summary
Phase III trial in Acute Lymphoblastic Leukemia completed with results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Acute Lymphoblastic Leukemia | Phase 3 | Status: COMPLETED | Results posted: 2021-07-21